CytoHub

Menu

Accelerating Regenerative Medicine

Empowering Cell & Gene Therapy with AI

with AI

The CytoHub Platform Quadrant

Recent News

Anand Giddabasappa, PhD of Pfizer joins CytoHub as an Advisor to advance AI-powered human mini-heart platform for cardiac pharmacology.

LA JOLLA, Calif.–(BUSINESS WIRE)–CytoHub, Inc., a pioneering developer of intelligent technologies for cell therapy and regenerative medicine, today announced the strategic addition of three top industry experts to its team.

Abbas Hashmi ABFP® of Saudi Family Holdings and Columbia Business School – Program Leader for Family Enterprises & Wealth joins as advisor.

LA JOLLA, Calif.–(BUSINESS WIRE)–CytoHub, Inc., a pioneering developer of intelligent technologies for cell therapy and regenerative medicine, today announced the strategic addition of three top industry experts to its team.

Mohammad El-Kalay, PhD joins CytoHub as an Advisor, brings 35+ years of TechOps leadership to advance the development of cell therapy products.

LA JOLLA, Calif.–(BUSINESS WIRE)–CytoHub, Inc., a pioneering developer of intelligent technologies for cell therapy and regenerative medicine, today announced the strategic addition of three top industry experts to its team.

Richard J. Anderson, Ph.D., joins CytoHub as VP, Technical Operations, brings over 25+ years technical leadership of cellular therapy products.

LA JOLLA, Calif.–(BUSINESS WIRE)–CytoHub, Inc., a pioneering developer of intelligent technologies for cell therapy and regenerative medicine, today announced the strategic addition of three top industry experts to its team.

Aitor Aguirre, Ph.D., Assc. Professor at the Department of Biomedical Eng. at MSU joins CytoHub as Co-Founder and Head of R&D.

LA JOLLA, Calif.–(BUSINESS WIRE)–CytoHub, Inc., a pioneering developer of intelligent technologies for cell therapy and regenerative medicine, today announced the strategic addition of three top industry experts to its team.

CardioVive™

Human Mini Heart Technology Platform State-of-the-art cardiac in vitro model Human mini heart with Atrium, Ventricle, Macrophages, Neural Crest, Fibroblasts, and all other cell types emulating 96% of human heart cells..

HeartReady™

Scale-up Solution Powered by AI Optimize process by identifying critical process parameters. Phase appropriate scale-up/down Industry leading expertise and relevant experience

Vascularized Cardiao

Transforming drug discovery, disease modeling, and heart muscle regeneration, paving the way for breakthrough therapies in cardiovascular care.

BioEngineAI™

Machine Learning-AI Technology Platform – developing and training models using multi-modal datasets to supercharge the development of regenerative medicines